{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T04:40:10Z","timestamp":1689655210872},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00105-014-3538-0","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T11:31:01Z","timestamp":1415964661000},"page":"1013-1016","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bull\u00f6ses Pemphigoid","Bullous pemphigoid"],"prefix":"10.1007","volume":"65","author":[{"given":"G.","family":"Balakirski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.F.","family":"Merk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Megahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"issue":"1","key":"3538_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195302000-00001","volume":"32","author":"WF Lever","year":"1953","unstructured":"Lever WF (1953) Pemphigus. Medicine (Baltimore) 32(1):1\u2013123","journal-title":"Medicine (Baltimore)"},{"key":"3538_CR2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3181\/00379727-117-29622","volume":"117","author":"EH Beutner","year":"1964","unstructured":"Beutner EH, Jordon RE (1964) Demonstration of skin antibodies in sera of pemphigus vuldaris patients by indirect immunofluorescent staining. Proc Soc Exp Biol Med 117:505\u2013510","journal-title":"Proc Soc Exp Biol Med"},{"issue":"9","key":"3538_CR3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jama.1967.03120220053008","volume":"200","author":"RE Jordon","year":"1967","unstructured":"Jordon RE, Beutner EH, Witebsky E, Blumental G, Hale WL, Lever WF (1967) Basement zone antibodies in bullous pemphigoid. JAMA 200(9):751\u2013756","journal-title":"JAMA"},{"issue":"3","key":"3538_CR4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0092-8674(81)90115-X","volume":"24","author":"JR Stanley","year":"1981","unstructured":"Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI (1981) Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 24(3):897\u2013903","journal-title":"Cell"},{"issue":"4","key":"3538_CR5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.136.4.1231","volume":"136","author":"RS Labib","year":"1986","unstructured":"Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA (1986) Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 136(4):1231\u20131235","journal-title":"J Immunol"},{"issue":"6","key":"3538_CR6","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI113803","volume":"82","author":"JR Stanley","year":"1988","unstructured":"Stanley JR, Tanaka T, Mueller S, Klaus-Kovtun V, Roop D (1988) Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. J Clin Invest 82(6):1864\u20131870","journal-title":"J Clin Invest"},{"issue":"12","key":"3538_CR7","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s001050051001","volume":"50","author":"W Kippes","year":"1999","unstructured":"Kippes W, Schmidt E, Roth A, Rzany B, Br\u00f6cker EB, Zillikens D (1999) Immunopathologic changes in 115 patients with bullous pemphigoid. Hautarzt 50(12):866\u2013872","journal-title":"Hautarzt"},{"issue":"5","key":"3538_CR8","first-page":"434","volume":"7","author":"F Bertram","year":"2009","unstructured":"Bertram F, Br\u00f6cker EB, Zillikens D, Schmidt E (2009) Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 7(5):434\u2013440","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"3538_CR9","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/bjd.12072","volume":"167","author":"VA Venning","year":"2012","unstructured":"Venning VA, Taghipour K, Mohd Mustapa MF, Highet AS, Kirtschig G (2012) British Association of Dermatologists\u2019 guidelines for the management of bullous pemphigoid 2012. Br J Dermatol 167(6):1200\u20131214","journal-title":"Br J Dermatol"},{"key":"3538_CR10","unstructured":"Megahed M (2012) Histopathology of blistering diseases. Springer, Berlin"},{"issue":"5741","key":"3538_CR11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/bmj.1.5741.144","volume":"1","author":"MW Greaves","year":"1971","unstructured":"Greaves MW, Burton JL, Marks J, Dawber RP (1971) Azathioprine in treatment of bullous pemphigoid. Br Med J 1(5741):144\u2013145","journal-title":"Br Med J"},{"issue":"12","key":"3538_CR12","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.143.12.1536","volume":"143","author":"S Beissert","year":"2007","unstructured":"Beissert S, Werfel T, Frieling U, B\u00f6hm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Bonsmann G, Luger TA (2007) A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. Arch Dermatol 143(12):1536\u20131542","journal-title":"Arch Dermatol"},{"issue":"5","key":"3538_CR13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/archderm.144.5.612","volume":"144","author":"P Kjellman","year":"2008","unstructured":"Kjellman P, Eriksson H, Berg P (2008) A retrospective analysis of patients with bullous pemphigoid treated with methotrexate. Arch Dermatol 144(5):612\u2013616","journal-title":"Arch Dermatol"},{"issue":"6","key":"3538_CR14","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1365-2133.2011.10531.x","volume":"165","author":"A Du-Thanh","year":"2001","unstructured":"Du-Thanh A, Merlet S, Maillard H, Bernard P, Joly P, Est\u00e8ve E, Richard MA, Pauwels C, Ingen-Housz-Oro S, Guillot B, Dereure O (2001) Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study. Br J Dermatol 165(6):1337\u20131343","journal-title":"Br J Dermatol"},{"issue":"4","key":"3538_CR15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0190-9622(96)80085-5","volume":"34","author":"F Bouscarat","year":"1996","unstructured":"Bouscarat F, Chosidow O, Picard-Dahan C, Sakiz V, Crickx B, Prost C, Roujeau JC, Revuz J, Belaich S (1996) Treatment of bullous pemphigoid with dapsone: retrospective study of thirty-six cases. J Am Acad Dermatol 34(4):683\u2013684","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3538_CR16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.1989.tb07769.x","volume":"120","author":"VA Venning","year":"1989","unstructured":"Venning VA, Millard PR, Wojnarowska F (1989) Dapsone as first line therapy for bullous pemphigoid. Br J Dermatol 120(1):83\u201392","journal-title":"Br J Dermatol"},{"issue":"1","key":"3538_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0190-9622(93)70013-J","volume":"28","author":"I Thomas","year":"1993","unstructured":"Thomas I, Khorenian S, Arbesfeld DM (1993) Treatment of generalized bullous pemphigoid with oral tetracycline. J Am Acad Dermatol 28 (1):74\u201377","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"3538_CR18","first-page":"309","volume":"113","author":"H Barth\u00e9l\u00e9my","year":"1986","unstructured":"Barth\u00e9l\u00e9my H, Thivolet J, Cambazard F, Bendelac A, Mauduit G, Granier F, Frappaz A (1986) Cyclosporin in the treatment of bullous pemphigoid: preliminary study. Ann Dermatol Venereol 113(4):309\u2013313","journal-title":"Ann Dermatol Venereol"},{"issue":"6","key":"3538_CR19","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/jdv.12155","volume":"28","author":"A Gual","year":"2014","unstructured":"Gual A, Iranzo P, Mascar\u00f3 JM Jr (2014) Treatment of bullous pemphigoid with low-dose oral cyclophosphamide: a case series of 20 patients. J Eur Acad Dermatol Venereol 28(6):814\u2013818","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"3538_CR20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.annder.2008.10.038","volume":"136","author":"Z Reguia\u00ef","year":"2009","unstructured":"Reguia\u00ef Z, Tchen T, Perceau G, Bernard P (2009) Efficacy of rituximab in a case of refractory bullous pemphigoid. Ann Dermatol Venereol 136(5):431\u2013434","journal-title":"Ann Dermatol Venereol"},{"key":"3538_CR21","doi-asserted-by":"crossref","unstructured":"Kasperkiewicz M, Shimanovich I, Ludwig RJ, Rose C, Zillikens D, Schmidt E (2011) Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients. J Am Acad Dermatol 65(3):552\u2013558","DOI":"10.1016\/j.jaad.2010.07.032"},{"issue":"5","key":"3538_CR22","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1111\/pde.12057","volume":"30","author":"I Fuertes","year":"2013","unstructured":"Fuertes I, Luelmo J, Leal L, Roman\u00ed J, S\u00e1nchez S, Mascar\u00f3 JM Jr (2013) Refractory childhood pemphigoid successfully treated with rituximab. Pediatr Dermatol 30(5):e96\u201397","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"3538_CR23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archderm.1974.01630090016003","volume":"110","author":"CE Arbesman","year":"1974","unstructured":"Arbesman CE, Wypych JI, Reisman RE, Beutner EH (1974) IgE levels in sera of patients with pemphigus or bullous pemphigoid. Arch Dermatol 110(3):378\u2013381","journal-title":"Arch Dermatol"},{"issue":"5","key":"3538_CR24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1523-1747.2003.12146.x","volume":"120","author":"OG Dimson","year":"2003","unstructured":"Dimson OG, Giudice GJ, Fu CL, Van den Bergh F, Warren SJ, Janson MM, Fairley JA (2003) Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid. J Invest Dermatol 120(5):784\u2013788","journal-title":"J Invest Dermatol"},{"issue":"4","key":"3538_CR25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2133.1993.tb00193.x","volume":"128","author":"H Soh","year":"1993","unstructured":"Soh H, Hosokawa H, Asada Y (1993) IgE and its related phenomena in bullous pemphigoid. Br J Dermatol 128(4):371\u2013377","journal-title":"Br J Dermatol"},{"issue":"8","key":"3538_CR26","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.4049\/jimmunol.157.8.3642","volume":"157","author":"E Delaporte","year":"1996","unstructured":"Delaporte E, Dubost-Brama A, Ghohestani R, Nicolas JF, Neyrinck JL, Bergoend H, Janin A, Capron M (1996) IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid. J Immunol 157(8):3642\u20133647","journal-title":"J Immunol"},{"issue":"2","key":"3538_CR27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2007.08.008","volume":"49","author":"N Ishiura","year":"2008","unstructured":"Ishiura N, Fujimoto M, Watanabe R, Nakashima H, Kuwano Y, Yazawa N, Echigo T, Okochi H, Tamaki K (2008) Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 49(2):153\u2013161","journal-title":"J Dermatol Sci"},{"issue":"1\u20132","key":"3538_CR28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jim.2009.04.013","volume":"346","author":"KA Messingham","year":"2009","unstructured":"Messingham KA, Noe MH, Chapman MA, Giudice GJ, Fairley JA (2009) A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid. J Immunol Methods 346(1\u20132):18\u201325","journal-title":"J Immunol Methods"},{"issue":"5","key":"3538_CR29","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-2133.2011.10481.x","volume":"165","author":"S Yayli","year":"2011","unstructured":"Yayli S, Pelivani N, Beltraminelli H, Wirthm\u00fcller U, Beleznay Z, Horn M, Borradori L (2011) Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis. Br J Dermatol 165 (5):1133\u20131137","journal-title":"Br J Dermatol"},{"issue":"11","key":"3538_CR30","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/sj.jid.5700958","volume":"127","author":"JA Fairley","year":"2007","unstructured":"Fairley JA, Burnett CT, Fu CL, Larson DL, Fleming MG, Giudice GJ (2007) A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu\/nu mice. J Invest Dermatol 127(11):2605\u20132611","journal-title":"J Invest Dermatol"},{"issue":"3","key":"3538_CR31","first-page":"523","volume":"60","author":"AD Yalcin","year":"2014","unstructured":"Yalcin AD, Genc GE, Celik B, Gumuslu S (2014) Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and its effects on soluble CD200. Clin Lab 60(3):523\u2013524","journal-title":"Clin Lab"},{"issue":"11","key":"3538_CR32","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/archdermatol.2012.1604","volume":"148","author":"VA London","year":"2012","unstructured":"London VA, Kim GH, Fairley JA, Woodley DT (2012) Successful treatment of bullous pemphigoid with omalizumab. Arch Dermatol 148(11):1241\u20131243","journal-title":"Arch Dermatol"},{"issue":"5","key":"3538_CR33","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1365-2133.2011.10748.x","volume":"166","author":"C Dufour","year":"2012","unstructured":"Dufour C, Souillet AL, Chaneliere C, Jouen F, Bodemer C, Jullien D, Cambazard F, Joly P, Reix P (2012) Successful management of severe infant bullous pemphigoid with omalizumab. Br J Dermatol 166(5):1140\u20131142","journal-title":"Br J Dermatol"},{"issue":"3","key":"3538_CR34","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2008.11.035","volume":"123","author":"JA Fairley","year":"2009","unstructured":"Fairley JA, Baum CL, Brandt DS, Messingham KA (2009) Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab. J Allergy Clin Immunol 123(3):704\u2013705","journal-title":"J Allergy Clin Immunol"},{"key":"3538_CR35","doi-asserted-by":"crossref","unstructured":"Yu KK, Crew AB, Messingham KA, Fairley JA, Woodley DT (2014). Omalizumab therapy for bullous pemphigoid. J Am Acad Dermatol. doi: 10.1016\/j.jaad.2014.04.053","DOI":"10.1016\/j.jaad.2014.04.053"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-014-3538-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-014-3538-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-014-3538-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T04:09:12Z","timestamp":1689653352000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-014-3538-0"}},"subtitle":["Ein neuer Blick auf eine bekannte Krankheit","A new look at a well-known disease"],"short-title":[],"issued":{"date-parts":[[2014,11,7]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3538"],"URL":"https:\/\/doi.org\/10.1007\/s00105-014-3538-0","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,7]]}}}